Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: A 24-week, randomized, placebo-controlled trial - Kovacs, C S; Seshiah, V; Swallow, R (Diabetes Obesity Metab, 2014)
et al.